LanBo Chen - TaiMed Biologics CoFounder
| 4147 Stock | TWD 87.50 0.10 0.11% |
Insider
LanBo Chen is CoFounder of TaiMed Biologics
| Phone | 886 2 2658 0058 |
| Web | https://www.taimedbiologics.com |
TaiMed Biologics Management Efficiency
The company has return on total asset (ROA) of (0.062) % which means that it has lost $0.062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1766) %, meaning that it generated substantial loss on money invested by shareholders. TaiMed Biologics' management efficiency ratios could be used to measure how well TaiMed Biologics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| ShiChung Chang | Medigen Biotechnology | 64 | |
| Mitchell MS | OBI Pharma | N/A | |
| Victoria Lin | OBI Pharma | N/A | |
| JenYang Chang | TTY Biopharm Co | N/A | |
| Kevin Poulos | OBI Pharma | 64 | |
| WeiYing Yin | TTY Biopharm Co | N/A | |
| Allen Chu | TTY Biopharm Co | N/A | |
| YuNan Shih | OBI Pharma | N/A | |
| ShuWen Wang | TTY Biopharm Co | N/A | |
| ShuFen Huang | TTY Biopharm Co | N/A | |
| Wayne MD | OBI Pharma | N/A | |
| YungMin Chiang | TTY Biopharm Co | N/A | |
| FACP FACP | OBI Pharma | 67 | |
| ChingLan Hou | TTY Biopharm Co | N/A | |
| Sharon Lee | OBI Pharma | N/A | |
| ChengEn Tsai | OBI Pharma | N/A | |
| MingTien Lai | OBI Pharma | N/A | |
| Yun Yan | OBI Pharma | N/A | |
| PoJen Chang | OBI Pharma | N/A | |
| SiYuan Yang | TTY Biopharm Co | N/A | |
| Wenlii Lin | Medigen Biotechnology | N/A | |
Management Performance
| Return On Equity | -0.18 | |||
| Return On Asset | -0.062 |
TaiMed Biologics Leadership Team
Elected by the shareholders, the TaiMed Biologics' board of directors comprises two types of representatives: TaiMed Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TaiMed. The board's role is to monitor TaiMed Biologics' management team and ensure that shareholders' interests are well served. TaiMed Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TaiMed Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| IngWen Tsai, CoFounder | ||
| GwoFong Lin, Independent Director | ||
| TaiHorng Young, Director | ||
| MingChing Chen, Independent Director | ||
| LungYeh Cho, Director | ||
| James Chang, Chairman of the Board, Chief Executive Officer | ||
| TienChieh Lee, Director | ||
| LanBo Chen, CoFounder | ||
| Jack Chen, Chief Financial Officer | ||
| ChiChuan Chen, Chairman of the Board | ||
| LuPing Chow, Director | ||
| Howard Lee, Independent Director | ||
| Qiankun Lin, Director | ||
| ChinMing Chang, Chief Technology Officer | ||
| Hui Zheng, Head Department | ||
| Tamon Tseng, Director | ||
| David MD, Chief CoFounder |
TaiMed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TaiMed Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.18 | |||
| Return On Asset | -0.062 | |||
| Profit Margin | (1.70) % | |||
| Operating Margin | (1.47) % | |||
| Current Valuation | 17.73 B | |||
| Shares Outstanding | 252.37 M | |||
| Shares Owned By Insiders | 17.27 % | |||
| Shares Owned By Institutions | 21.66 % | |||
| Price To Book | 6.45 X | |||
| Price To Sales | 55.99 X |
Pair Trading with TaiMed Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TaiMed Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TaiMed Biologics will appreciate offsetting losses from the drop in the long position's value.Moving against TaiMed Stock
The ability to find closely correlated positions to TaiMed Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TaiMed Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TaiMed Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TaiMed Biologics to buy it.
The correlation of TaiMed Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TaiMed Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TaiMed Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TaiMed Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.